Full history for every metric is available with a Kvantra account
Chr. Hansen Holding A/S (CHR.CO)
Key financial summary
Financials in EUR| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 1,097 | 1,161 | 970 | 1,077 | 1,218 | 1,334 | 1,334 |
| Operating profit | €m | 359 | 350 | |||||
| Net profit | €m | 228 | 250 | 245 | 199 | 225 | 227 | 227 |
| EPS reported | € | 1.72 | 1.72 | |||||
| Operating cashflow per share | € | 2.40 | 2.40 | |||||
| Capex per share | € | 0.88 | 0.88 | |||||
| FCF per share | € | 1.52 | 1.52 | |||||
| Free cash flow | €m | 201 | 187 | |||||
| Net debt | €m | - | - | |||||
| Book value equity | €m | 1,900 | 1,900 | |||||
| Book value per share | € | 14.40 | 14.19 | |||||
| Number of shares | m | 131.98 | 133.89 | |||||
| DPS (TTM paid) | € | 1.03 | 1.03 |
Financial summary
Financials in EUR| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 35.04 | - | |||||
| P/B LTM | x | 4.18 | 5.09 | |||||
| P/S LTM | x | 5.96 | 7.25 | |||||
| P/FCF LTM | x | 39.62 | 51.88 | |||||
| EV/EBITDA LTM | x | 16.70 | 20.47 | |||||
| EV/Sales LTM | x | 0.00 | 7.25 | |||||
| Earnings Yield LTM | % | 2.85% | 2.34% | |||||
| FCF Yield | % | 2.52% | 1.93% | |||||
| Quality | ||||||||
| ROE | % | 11.95% | 21.82% | |||||
| ROIC | % | 0.00% | 0.00% | |||||
| Operating margin | % | 26.89% | 26.89% | |||||
| Gross margin | % | 54.20% | 54.20% | |||||
| FCF/Sales | % | 15.04% | 15.04% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | +0.58% | +0.58% | |||||
| Sales Growth YoY | % | +9.56% | +9.56% | |||||
| Net Income Growth YoY | % | +0.84% | +0.84% | |||||
| FCF Growth | % | +20.04% | +20.04% | |||||
| Operating Profit Growth | % | +11.81% | +11.81% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 1.57% | 1.40% | |||||
| Dividend Growth | % | +9.36% | - | |||||
| Payout Ratio | % | 54.93% | 54.95% | |||||
| FCF/Debt | x | - | - | |||||
| Net Debt/EBITDA | x | 0.00 | 0.00 | |||||
| EBIT/Net interest | x | 0.00 | 0.00 | |||||
| Net debt/market cap | % | - | - | |||||
| Net debt/Equity | x | - | - | |||||
| Gross debt/equity | x | - | - | |||||
Company overview
Chr. Hansen Holding A/S is a prominent bioscience firm that develops natural ingredient solutions for a diverse global market, including the food, nutritional, pharmaceutical, and agricultural sectors across Europe, the Middle East, Africa, the Americas, and Asia Pacific. The company's operations are divided into two main segments: Food Cultures & Enzymes, and Health & Nutrition. The Food Cultures & Enzymes division provides a variety of cultures, enzymes, and probiotic products crucial for enhancing the taste, flavor, texture, longevity, nutritional content, and health advantages of consumer goods, primarily within the dairy industry. Concurrently, the Health & Nutrition segment manufactures and distributes products catering to the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. Additionally, Chr. Hansen has forged a strategic partnership with UPL Ltd. to jointly create and commercialize microbial bio-solutions that promote sustainable agriculture. Founded in 1843, the company's corporate headquarters are located in Hørsholm, Denmark.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Chr. Hansen Holding A/S (CHR.CO)
Chr. Hansen Holding A/S is a prominent bioscience firm that develops natural ingredient solutions for a diverse global market, including the food, nutritional, pharmaceutical, and agricultural sectors across Europe, the Middle East, Africa, the Americas, and Asia Pacific. The company's operations are divided into two main segments: Food Cultures & Enzymes, and Health & Nutrition. The Food Cultures & Enzymes division provides a variety of cultures, enzymes, and probiotic products crucial for enhancing the taste, flavor, texture, longevity, nutritional content, and health advantages of consumer goods, primarily within the dairy industry. Concurrently, the Health & Nutrition segment manufactures and distributes products catering to the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. Additionally, Chr. Hansen has forged a strategic partnership with UPL Ltd. to jointly create and commercialize microbial bio-solutions that promote sustainable agriculture. Founded in 1843, the company's corporate headquarters are located in Hørsholm, Denmark.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free